Laurence de Schoulepnikoff
Chief Operating Officer
Laurence joined AMAL Therapeutics in January 2019.
Laurence has over twenty-five years of professional experience with broad expertise in business development and transactions in the pharmaceutical industry, in particular in structuring and negotiating licensing-in/out and acquisition/divestment deals. She benefits from an in-depth understanding of the strategic and financial drivers as well as the regulatory and legal environment. She has a strong scientific background with extensive experience in alliance management, strategic sourcing and supply chain.